Tag: Placebo

Latest News

UTHealth tests arthritis drug's effect on COVID-19-induced cytokine storm

Newsemia
A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers at...
Gastroenterology

Novel antisense drug shows promise to improve health of people with NAFLD

Newsemia
Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San Diego School of Medicine...
Latest News

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Newsemia
Empagliflozin (EMPA), a selective inhibitor of sodium/glucose cotransporter 2 (SGLT2 inhibitors, “gliflozines”), reduces CKD progression in type 2 diabetics (T2D) with cardiovascular disease, presumably by...
Latest News

Human Testing Of Coronavirus Vaccine Candidates To Commence In July

Newsemia
Per the NIH director, at least one safe and effective vaccine for the coronavirus should be available by the end of the year, what with...
Neurology

Cancer drug nilotinib found to be safe and well-tolerated in Alzheimer's disease clinical trial

Newsemia
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and...
Gastroenterology

Global study to test whether antimalaria drug can prevent COVID-19 in health-care workers

Newsemia
With $9 million in philanthropic support, an international group of physicians and scientists is establishing a research network to evaluate promising therapies for COVID-19. Source...
Latest News

Clinical trial to evaluate experimental COVID-19 drug is underway at Montefiore and Einstein

Newsemia
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are...
Latest News

Investigational Drug Vericiguat Significantly Reduced the Risk of the Composite Endpoint of Heart Failure Hospitalization or Cardiovascular Death, Compared to Placebo, When Given in Combination with Available Heart Failure Therapies

Newsemia
KENILWORTH, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Investigational Drug Vericiguat Significantly Reduced the Risk of the Composite Endpoint of Heart Failure Hospitalization or Cardiovascular Death Source link...
Gastroenterology

Investigational drug reduces heartburn severity in patients with refractory GERD

Newsemia
An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD)...
Latest News

Cocoa consumption may improve walking performance in peripheral artery disease patients

Newsemia
Consumption of cocoa may improve walking performance for patients with peripheral artery disease, according to the results of a small, preliminary, phase II research trial...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World